These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19023029)

  • 1. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.
    Mani AR; Montagnese S; Jackson CD; Jenkins CW; Head IM; Stephens RC; Moore KP; Morgan MY
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G330-8. PubMed ID: 19023029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
    Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
    Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
    Montagnese S; Gordon HM; Jackson C; Smith J; Tognella P; Jethwa N; Sherratt RM; Morgan MY
    Hepatology; 2005 Oct; 42(4):772-81. PubMed ID: 16175619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?
    Goral V; Atayan Y; Kaplan A
    Hepatogastroenterology; 2011; 58(107-108):943-8. PubMed ID: 21830421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ dysfunction in cirrhosis: a mechanism involving the microcirculation.
    Brito-Azevedo A; Perez RM; Maranhão PA; Coelho HS; Fernandes ESM; Castiglione RC; de Souza MD; Villela-Nogueira CA; Bouskela E
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):618-625. PubMed ID: 30920976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
    Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of the interaction between short-term, metronome-paced heart rate variability, and inflammation: results from the population-based CARLA cohort study.
    Medenwald D; Swenne CA; Loppnow H; Kors JA; Pietzner D; Tiller D; Thiery J; Nuding S; Greiser KH; Haerting J; Werdan K; Kluttig A
    Europace; 2017 Jan; 19(1):110-118. PubMed ID: 27221352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
    Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1112-1119. PubMed ID: 31583743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    Tsai CF; Chu CJ; Huang YH; Wang YP; Liu PY; Lin HC; Lee FY; Lu CL
    PLoS One; 2015; 10(6):e0128437. PubMed ID: 26039496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
    Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
    Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum interleukin-6, not minimal hepatic encephalopathy, predicts poor sleep quality in nonalcoholic cirrhotic patients.
    Tsai CF; Chu CJ; Wang YP; Liu PY; Huang YH; Lin HC; Lee FY; Lu CL
    Aliment Pharmacol Ther; 2016 Oct; 44(8):836-45. PubMed ID: 27518472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and heart rate variability in patients with chronic heart failure.
    Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
    Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of heart rate variability with severity and prognosis of cirrhosis.
    Ates F; Topal E; Kosar F; Karincaoglu M; Yildirim B; Aksoy Y; Aladag M; Harputluoglu MM; Demirel U; Alan H; Hilmioglu F
    Dig Dis Sci; 2006 Sep; 51(9):1614-8. PubMed ID: 16927142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.